Officially: Safeguarding Women from Chemical Abortion Act
Mifepristone could no longer have federal approval for ending a pregnancy inside the uterus. The bill would also let people sue the drug maker for certain physical or mental health harms tied to the drug.
Where it stands
Sitting in Health
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in Senate
Senate Committee
Under Senate committee consideration
Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (3/11/2026)
Senate Floor Vote
Voted on by Senate
Passed Senate
Approved by Senate
House Review
Sent to House for consideration
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
